Reviva Pharmaceuticals announces pricing of $9M public offering

MSN
2025.09.19 04:48
portai
I'm PortAI, I can summarize articles.

Reviva Pharmaceuticals（納斯達克代碼：RVPH）宣佈公開發行 2700 萬股普通股，以及 E 系列和 F 系列認股權證，定價為每股 0.335 美元，預計總收益約為 900 萬美元。該公司計劃將淨收益用於研發、營運資金及其他一般企業用途

Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.